These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 25792203)

  • 1. Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria.
    Bassetti M; De Waele JJ; Eggimann P; Garnacho-Montero J; Kahlmeter G; Menichetti F; Nicolau DP; Paiva JA; Tumbarello M; Welte T; Wilcox M; Zahar JR; Poulakou G
    Intensive Care Med; 2015 May; 41(5):776-95. PubMed ID: 25792203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic stewardship in sepsis management: toward a balanced use of antibiotics for the severely ill patient.
    De Waele JJ; Dhaese S
    Expert Rev Anti Infect Ther; 2019 Feb; 17(2):89-97. PubMed ID: 30672354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation.
    Campion M; Scully G
    J Intensive Care Med; 2018 Dec; 33(12):647-655. PubMed ID: 29534630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key Challenges in Providing Effective Antibiotic Therapy for Critically Ill Patients with Bacterial Sepsis and Septic Shock.
    Landersdorfer CB; Nation RL
    Clin Pharmacol Ther; 2021 Apr; 109(4):892-904. PubMed ID: 33570163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic strategies in the treatment of infection in critically ill patients].
    Schierbeck J; Kolmos HJ
    Ugeskr Laeger; 2007 Feb; 169(8):699-702. PubMed ID: 17313920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic dosing for multidrug-resistant pathogen pneumonia.
    Abdul-Aziz MH; Lipman J; Roberts JA
    Curr Opin Infect Dis; 2017 Apr; 30(2):231-239. PubMed ID: 28030371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and appropriateness of novel antibiotics in response to antimicrobial-resistant gram-negative bacteria in patients with sepsis in the ICU.
    Garduno A; Martín-Loeches I
    Expert Rev Anti Infect Ther; 2022 Apr; 20(4):513-531. PubMed ID: 34727820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bloodstream infections in critically ill patients: an expert statement.
    Timsit JF; Ruppé E; Barbier F; Tabah A; Bassetti M
    Intensive Care Med; 2020 Feb; 46(2):266-284. PubMed ID: 32047941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How could we reduce antibiotic use in critically ill patients?
    De Angelis G; Restuccia G; Cauda R; Tacconelli E
    Infect Disord Drug Targets; 2011 Aug; 11(4):376-83. PubMed ID: 21679144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De-escalation antimicrobial chemotherapy in critically III patients: pros and cons.
    Antonelli M; Mercurio G; Di Nunno S; Recchioni G; Deangelis G
    J Chemother; 2001 Nov; 13 Spec No 1(1):218-23. PubMed ID: 11936369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial stewardship: bridging the gap between quality care and cost.
    Goff DA
    Curr Opin Infect Dis; 2011 Feb; 24 Suppl 1():S11-20. PubMed ID: 21200180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Strategies targeted at optimising antimicrobial therapy in critically ill patients].
    Eggimann P; Oddo M; Voirol P; Zanetti G; Chioléro R
    Rev Med Suisse; 2005 Dec; 1(45):2928-32. PubMed ID: 16425950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics in critically ill children-a narrative review on different aspects of a rational approach.
    Bruns N; Dohna-Schwake C
    Pediatr Res; 2022 Jan; 91(2):440-446. PubMed ID: 34873285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confronting the threat of multidrug-resistant Gram-negative bacteria in critically ill patients.
    Cohen J
    J Antimicrob Chemother; 2013 Mar; 68(3):490-1. PubMed ID: 23152481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
    Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
    Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous colistin for multidrug-resistant gram-negative infections in critically ill pediatric patients.
    Kapoor K; Jajoo M; Dublish S; Dabas V; Gupta S; Manchanda V
    Pediatr Crit Care Med; 2013 Jul; 14(6):e268-72. PubMed ID: 23689704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surviving Sepsis in the Intensive Care Unit: The Challenge of Antimicrobial Resistance and the Trauma Patient.
    Ramsamy Y; Hardcastle TC; Muckart DJJ
    World J Surg; 2017 May; 41(5):1165-1169. PubMed ID: 27146052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms.
    Niederman MS
    Clin Infect Dis; 2006 Jan; 42 Suppl 2():S72-81. PubMed ID: 16355320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.